NextCure News

NextCure Analyst Ratings

BenzingaJun 3 06:47 ET

NextCure Analyst Ratings

BenzingaMay 31 06:26 ET

NextCure Analyst Ratings

BenzingaMay 3 16:03 ET

Promising Clinical Outlook for NextCure's Novel ADC LNCB74 Spurs Buy Rating

TipRanksApr 8 11:45 ET

NextCure Analyst Ratings

BenzingaMar 22 14:14 ET

Analysts Offer Insights on Healthcare Companies: Femasys (FEMY) and NextCure (NXTC)

TipRanksMar 21 14:30 ET

Needham Maintains Buy on NextCure, Lowers Price Target to $4

BenzingaDec 14, 2023 11:30 ET

NextCure Analyst Ratings

BenzingaDec 14, 2023 11:30 ET

NextCure (NXTC) Gets a Buy From Piper Sandler

TipRanksNov 3, 2023 06:43 ET

Analysts Offer Insights on Healthcare Companies: Repare Therapeutics (RPTX), Cigna (CI) and NextCure (NXTC)

TipRanksSep 27, 2023 06:50 ET

NextCure (NXTC) Initiated With a Buy at H.C. Wainwright

TipRanksAug 8, 2023 06:15 ET

HC Wainwright & Co. Initiates Coverage On NextCure With Buy Rating, Announces Price Target of $7

BenzingaAug 8, 2023 06:11 ET

NextCure Analyst Ratings

BenzingaAug 8, 2023 06:10 ET

Piper Sandler Remains a Buy on NextCure (NXTC)

TipRanksAug 7, 2023 08:16 ET

Needham Reiterates Buy on NextCure, Maintains $6 Price Target

BenzingaAug 4, 2023 06:25 ET

NextCure Analyst Ratings

BenzingaAug 4, 2023 06:25 ET

NextCure (NXTC) Gets a Buy From Needham

TipRanksMay 5, 2023 08:42 ET

Needham Reiterates Buy on NextCure, Maintains $6 Price Target

BenzingaMay 5, 2023 05:28 ET

Needham Remains a Buy on NextCure (NXTC)

TipRanksMar 3, 2023 07:36 ET

Needham Reiterates Buy on NextCure, Maintains $6 Price Target

BenzingaMar 3, 2023 05:14 ET